Anthelmintics Is Fastest Growing Segment Fueling The Growth Of Fascioliasis Market
Fascioliasis Market The global Fascioliasis Market is estimated to be valued at US$ 361.3 Mn or Million in 2023 and is expected to exhibit a CAGR of 4.5% over the forecast period 2023 to 2030 , as highlighted in a new report published by Coherent Market Insights. Market Overview: Fascioliasis is a foodborne disease caused by liver fluke parasites known as Fasciola hepatica and Fasciola gigantica. Anthelmintic drugs are essential in treating fascioliasis infection and helps control further spread of infection. Market key trends: Rising prevalence of fascioliasis globally has increased the demand for effective diagnosis and treatment of the disease. As per WHO study published in 2020, over 2.4 million people are estimated to be infected with fascioliasis globally which is fueling the sales of anthelmintic drugs developed for fascioliasis treatment. Drugmakers are focusing on developing novel and effective anthelmintic drugs with higher efficacy and safety for long-term treatment ...